ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

RTTNews | 809 dni temu
ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

(RTTNews) - Immuno-oncology company ALX Oncology Holdings Inc. (ALXO) announced Tuesday positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company's CD47 blocking therapeutic, in combination with trastuzumab, CYRAMZA (ramucirumab) and paclitaxel for the treatment of patients with HER2-positive gastric/gastroesophageal junction (GEJ) cancer.

Evorpacept is the first CD47 blocker to show activity in a global randomized study in solid tumors.

The interim efficacy results showed the confirmed overall response rate for evorpacept combination treatment was 52% compared to 22% for control treatment.

This prespecified interim analysis represents results from 54 randomized patients with second and third line gastric/GEJ cancer, including a meaningful number of patients previously treated with ENHERTU (trastuzumab deruxtecan) and checkpoint inhibitors.

Patients were treated with evorpacept at 30 mg/kg every two weeks, mirroring the treatment cycle of trastuzumab, CYRAMZA and paclitaxel.

read more
European Markets Close Higher As Stocks Recover After Cautious Start

European Markets Close Higher As Stocks Recover After Cautious Start

European stocks closed higher on Friday, and several markets in the region climbed to fresh highs, with investors reacting to the interest rate decisions by major central banks. Expectations of more monetary easing by the Federal Reserve contributed as well to the positive mood in the markets.
RTTNews | 15g 0 minut temu
U.S. Consumer Sentiment Rebounds Less Than Previously Estimated In December

U.S. Consumer Sentiment Rebounds Less Than Previously Estimated In December

Consumer sentiment in the U.S. rebounded by less than previously estimates in the month of December, according to revised data released by the University of Michigan on Friday. The University of Michigan said its consumer sentiment index for December was downwardly revised to 52.9 from a preliminary reading of 53.3. Economists had expected the index to be upwardly revised to 53.4.
RTTNews | 17g 10 minut temu
U.S. Existing Home Sales Rise Less Than Expected In November

U.S. Existing Home Sales Rise Less Than Expected In November

Existing home sales in the U.S. saw a modest increase in the month of November, the National Association of Realtors revealed in a report released on Friday. NAR said existing home sales rose by 0.5 percent to an annual rate of 4.13 million in November after jumping by 1.5 percent to an upwardly revised rate of 4.10 million in October.
RTTNews | 17g 21 minut temu
Russia Cuts Key Rate By 50 Bps As Expected

Russia Cuts Key Rate By 50 Bps As Expected

Russia's central bank cut its interest rate by 50 basis points on Friday but reiterated that it will maintain policy tight to bring inflation back to the target. The Board of Directors, led by Governor Elvira Nabiullina, decided to cut the key rate to 16.00 percent from 16.50 percent. The decision matched market expectations. The bank has lowered the interest rate by 400 basis points since Jun
RTTNews | 19g 9 minut temu
Bay Street May Open Slightly Higher

Bay Street May Open Slightly Higher

The Canadian market, which snapped a four-day losing streak on Thursday, looks headed for a positive start Friday morning. Canadian retail sales data, and U.S. PCE reading are likely to make an impact.
RTTNews | 19g 49 minut temu